Literature DB >> 29465288

Origin and Consequences of Necroinflammation.

Maysa Sarhan1, Walter G Land1, Wulf Tonnus1, Christian P Hugo1, Andreas Linkermann1.   

Abstract

When cells undergo necrotic cell death in either physiological or pathophysiological settings in vivo, they release highly immunogenic intracellular molecules and organelles into the interstitium and thereby represent the strongest known trigger of the immune system. With our increasing understanding of necrosis as a regulated and genetically determined process (RN, regulated necrosis), necrosis and necroinflammation can be pharmacologically prevented. This review discusses our current knowledge about signaling pathways of necrotic cell death as the origin of necroinflammation. Multiple pathways of RN such as necroptosis, ferroptosis, and pyroptosis have been evolutionary conserved most likely because of their differences in immunogenicity. As the consequence of necrosis, however, all necrotic cells release damage associated molecular patterns (DAMPs) that have been extensively investigated over the last two decades. Analysis of necroinflammation allows characterizing specific signatures for each particular pathway of cell death. While all RN-pathways share the release of DAMPs in general, most of them actively regulate the immune system by the additional expression and/or maturation of either pro- or anti-inflammatory cytokines/chemokines. In addition, DAMPs have been demonstrated to modulate the process of regeneration. For the purpose of better understanding of necroinflammation, we introduce a novel classification of DAMPs in this review to help detect the relative contribution of each RN-pathway to certain physiological and pathophysiological conditions.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29465288     DOI: 10.1152/physrev.00041.2016

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  48 in total

1.  Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis.

Authors:  Alexia Belavgeni; Stefan R Bornstein; Anne von Mässenhausen; Wulf Tonnus; Julian Stumpf; Claudia Meyer; Evelyn Othmar; Markus Latk; Waldemar Kanczkowski; Matthias Kroiss; Constanze Hantel; Christian Hugo; Martin Fassnacht; Christian G Ziegler; Andrew V Schally; Nils P Krone; Andreas Linkermann
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

Review 2.  Drug-induced tubulointerstitial nephritis: hypersensitivity and necroinflammatory pathways.

Authors:  Allison A Eddy
Journal:  Pediatr Nephrol       Date:  2019-02-28       Impact factor: 3.714

3.  Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation.

Authors:  Wenjun Li; Guoshuai Feng; Jason M Gauthier; Inessa Lokshina; Ryuji Higashikubo; Sarah Evans; Xinping Liu; Adil Hassan; Satona Tanaka; Markus Cicka; Hsi-Min Hsiao; Daniel Ruiz-Perez; Andrea Bredemeyer; Richard W Gross; Douglas L Mann; Yulia Y Tyurina; Andrew E Gelman; Valerian E Kagan; Andreas Linkermann; Kory J Lavine; Daniel Kreisel
Journal:  J Clin Invest       Date:  2019-02-26       Impact factor: 14.808

4.  Emerging Role for Ferroptosis in Infectious Diseases.

Authors:  Eduardo Pinheiro Amaral; Sivaranjani Namasivayam
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Glucocorticoids limit lipopolysaccharide-induced lethal inflammation by a double control system.

Authors:  Kelly Van Looveren; Steven Timmermans; Tineke Vanderhaeghen; Charlotte Wallaeys; Marlies Ballegeer; Jolien Souffriau; Melanie Eggermont; Jolien Vandewalle; Lise Van Wyngene; Karolien De Bosscher; Claude Libert
Journal:  EMBO Rep       Date:  2020-05-08       Impact factor: 8.807

Review 6.  Redox (phospho)lipidomics of signaling in inflammation and programmed cell death.

Authors:  Yulia Y Tyurina; Claudette M St Croix; Simon C Watkins; Alan M Watson; Michael W Epperly; Tamil S Anthonymuthu; Elena R Kisin; Irina I Vlasova; Olga Krysko; Dmitri V Krysko; Alexandr A Kapralov; Haider H Dar; Vladimir A Tyurin; Andrew A Amoscato; Elena N Popova; Sergey B Bolevich; Peter S Timashev; John A Kellum; Sally E Wenzel; Rama K Mallampalli; Joel S Greenberger; Hulya Bayir; Anna A Shvedova; Valerian E Kagan
Journal:  J Leukoc Biol       Date:  2019-05-09       Impact factor: 4.962

Review 7.  Necroptosis: a crucial pathogenic mediator of human disease.

Authors:  Mary E Choi; David R Price; Stefan W Ryter; Augustine M K Choi
Journal:  JCI Insight       Date:  2019-08-08

8.  Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3.

Authors:  Xiaofei Chen; Chunlin Zhuang; Yibin Ren; Hao Zhang; Xia Qin; Longmiao Hu; Jing Fu; Zhenyuan Miao; Yifeng Chai; Zheng-Gang Liu; Haibing Zhang; Zhenyu Cai; Hong-Yang Wang
Journal:  Br J Pharmacol       Date:  2019-05-06       Impact factor: 8.739

9.  Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease.

Authors:  Sarah I Landau; Xiaojia Guo; Heino Velazquez; Richard Torres; Eben Olson; Rolando Garcia-Milian; Gilbert W Moeckel; Gary V Desir; Robert Safirstein
Journal:  Kidney Int       Date:  2019-04       Impact factor: 10.612

Review 10.  Programmed Necrosis and Disease:We interrupt your regular programming to bring you necroinflammation.

Authors:  Eui Ho Kim; Sing-Wai Wong; Jennifer Martinez
Journal:  Cell Death Differ       Date:  2018-10-22       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.